{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:10:50Z","timestamp":1790950250658,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPD190121-3"],"award-info":[{"award-number":["CMRPD190121-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPD190361-4"],"award-info":[{"award-number":["CMRPD190361-4"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CLRPD190013"],"award-info":[{"award-number":["CLRPD190013"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"crossref","award":["NHRI-EX101-10015BI"],"award-info":[{"award-number":["NHRI-EX101-10015BI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science Council of Taiwan, Republic of China","award":["NSC99-2320-B-182-017-MY3"],"award-info":[{"award-number":["NSC99-2320-B-182-017-MY3"]}]},{"name":"National Science Council of Taiwan, Republic of China","award":["NSC102-2325-B-182-010"],"award-info":[{"award-number":["NSC102-2325-B-182-010"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jprot.2013.09.013","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T22:46:22Z","timestamp":1380321982000},"page":"186-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Low-molecular-mass secretome profiling identifies C\u2013C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"94","author":[{"given":"Shih-Jie","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Ping","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang-Ming","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Yi","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jau-Song","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2013.09.013_bb0005","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma","volume":"365","author":"Wei","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jprot.2013.09.013_bb0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0360-3016(00)00779-3","article-title":"Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy","volume":"48","author":"Cheng","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jprot.2013.09.013_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","article-title":"Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival","volume":"21","author":"Lin","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.mlg.0000201993.53410.40","article-title":"The 30-bp deletion of Epstein\u2013Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma","volume":"116","author":"Chang","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jprot.2013.09.013_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0360-3016(92)90740-9","article-title":"Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976\u20131985: overall survival and patterns of failure","volume":"23","author":"Lee","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jprot.2013.09.013_bb0030","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.28.11.2398-2402.1990","article-title":"Detection of Epstein\u2013Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification","volume":"28","author":"Chang","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0035","first-page":"297","article-title":"Epstein\u2013Barr virus and nasopharyngeal carcinoma","volume":"3","author":"Raab-Traub","year":"1992","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910170102","article-title":"Epstein\u2013Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma","volume":"17","author":"Henle","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jprot.2013.09.013_bb0045","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/bjc.1976.228","article-title":"Epstein\u2013Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma","volume":"34","author":"Ho","year":"1976","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jprot.2013.09.013_bb0050","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein\u2013Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jprot.2013.09.013_bb0055","first-page":"1188","article-title":"Quantitative analysis of cell-free Epstein\u2013Barr virus DNA in plasma of patients with nasopharyngeal carcinoma","volume":"59","author":"Lo","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-6-1","article-title":"Nasopharyngeal carcinoma: molecular biomarker discovery and progress","volume":"6","author":"Cho","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jprot.2013.09.013_bb0065","first-page":"3752","article-title":"Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size","volume":"55","author":"Yuan","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0070","first-page":"2136","article-title":"Pro-gastrin-releasing peptide (31\u201398) is a specific tumor marker in patients with small cell lung carcinoma","volume":"54","author":"Miyake","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0075","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1158\/1078-0432.CCR-08-0090","article-title":"Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes","volume":"14","author":"Chang","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"Suppl. 2","key":"10.1016\/j.jprot.2013.09.013_bb0080","first-page":"cclvi","article-title":"Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer","volume":"50","author":"Triantafillidis","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jprot.2013.09.013_bb0085","first-page":"66","article-title":"Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck","volume":"48","author":"Strojan","year":"2001","journal-title":"Neoplasma"},{"key":"10.1016\/j.jprot.2013.09.013_bb0090","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2004.10.036","article-title":"Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis","volume":"96","author":"Tsukishiro","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0095","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1074\/mcp.M300031-MCP200","article-title":"Characterization of the low molecular weight human serum proteome","volume":"2","author":"Tirumalai","year":"2003","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jprot.2009.09.013","article-title":"A centrifugal ultrafiltration strategy for isolating the low-molecular weight (<or=25K) component of human plasma proteome","volume":"73","author":"Greening","year":"2010","journal-title":"J Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/pmic.200900346","article-title":"Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome","volume":"10","author":"Bouamrani","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0110","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1002\/pmic.200500774","article-title":"A novel approach and protocol for discovering extremely low-abundance proteins in serum","volume":"6","author":"Tanaka","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/prca.200600618","article-title":"A method for the selective isolation and enrichment of carrier protein-bound low-molecular weight proteins and peptides in the blood","volume":"1","author":"Camerini","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2013.09.013_bb0120","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1002\/rcm.3729","article-title":"Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis","volume":"22","author":"Kay","year":"2008","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.jprot.2013.09.013_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.aca.2012.06.033","article-title":"Comparison of three different enrichment strategies for serum low molecular weight protein identification using shotgun proteomics approach","volume":"740","author":"Capriotti","year":"2012","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.jprot.2013.09.013_bb0130","series-title":"Low-abundance protein discovery: state of the art and protocols","author":"Boschetti","year":"2013"},{"key":"10.1016\/j.jprot.2013.09.013_bb0135","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/pmic.200300703","article-title":"Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: landscaping activity of Smad4 as revealed by a \u201csecretome\u201d analysis","volume":"4","author":"Volmer","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0140","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/pmic.200401133","article-title":"Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model","volume":"5","author":"Wu","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/pmic.201100346","article-title":"Secreted proteins as a fundamental source for biomarker discovery","volume":"12","author":"Stastna","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0150","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.jprot.2010.04.003","article-title":"The cancer cell secretome: a good source for discovering biomarkers?","volume":"73","author":"Pavlou","year":"2010","journal-title":"J Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0155","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jprot.2010.07.001","article-title":"Secretome proteomics for discovery of cancer biomarkers","volume":"73","author":"Makridakis","year":"2010","journal-title":"J Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0160","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1021\/pr0702060","article-title":"How shall we use the proteomics toolbox for biomarker discovery?","volume":"6","author":"Lescuyer","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0165","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1074\/mcp.M900398-MCP200","article-title":"Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas","volume":"9","author":"Wu","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nprot.2006.4","article-title":"Tricine\u2013SDS-PAGE","volume":"1","author":"Schagger","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jprot.2013.09.013_bb0175","first-page":"716","article-title":"Characterization of seven newly established nasopharyngeal carcinoma cell lines","volume":"68","author":"Lin","year":"1993","journal-title":"Lab Invest"},{"key":"10.1016\/j.jprot.2013.09.013_bb0180","first-page":"713","article-title":"Establishment and characterization of two nasopharyngeal carcinoma cell lines","volume":"62","author":"Lin","year":"1990","journal-title":"Lab Invest"},{"key":"10.1016\/j.jprot.2013.09.013_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-4608(97)00416-0","article-title":"Chromosomal abnormalities of a new nasopharyngeal carcinoma cell line (NPC-BM1) derived from a bone marrow metastatic lesion","volume":"103","author":"Liao","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jprot.2013.09.013_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/protein\/10.1.1","article-title":"Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites","volume":"10","author":"Nielsen","year":"1997","journal-title":"Protein Eng"},{"key":"10.1016\/j.jprot.2013.09.013_bb0195","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nmeth.1701","article-title":"SignalP 4.0: discriminating signal peptides from transmembrane regions","volume":"8","author":"Petersen","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.jprot.2013.09.013_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/protein\/gzh037","article-title":"Feature-based prediction of non-classical and leaderless protein secretion","volume":"17","author":"Bendtsen","year":"2004","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.jprot.2013.09.013_bb0205","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/bioinformatics\/17.7.646","article-title":"Evaluation of methods for the prediction of membrane spanning regions","volume":"17","author":"Moller","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/path.2487","article-title":"The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma","volume":"217","author":"Bose","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0215","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1158\/0008-5472.CAN-05-4399","article-title":"Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma","volume":"66","author":"Sengupta","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0220","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1158\/1055-9965.EPI-06-0455","article-title":"Genes involved in DNA repair and nitrosamine metabolism and those located on chromosome 14q32 are dysregulated in nasopharyngeal carcinoma","volume":"15","author":"Dodd","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jprot.2013.09.013_bb0225","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.jprot.2013.09.013_bb0230","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1002\/pmic.200800877","article-title":"Nanozeolite-driven approach for enrichment of secretory proteins in human hepatocellular carcinoma cells","volume":"9","author":"Cao","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0235","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1093\/bioinformatics\/bti610","article-title":"Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research","volume":"21","author":"Conesa","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0240","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/pmic.200900620","article-title":"Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis","volume":"10","author":"Chang","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0245","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hed.21557","article-title":"Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival","volume":"33","author":"Chang","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.jprot.2013.09.013_bb0250","first-page":"495","article-title":"Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis","volume":"24","author":"Tang","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jprot.2013.09.013_bb0255","doi-asserted-by":"crossref","first-page":"e28842","DOI":"10.1371\/journal.pone.0028842","article-title":"CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRbeta in colorectal carcinoma","volume":"6","author":"Cambien","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jprot.2013.09.013_bb0260","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/stem.1194","article-title":"Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation","volume":"30","author":"Long","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.jprot.2013.09.013_bb0265","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bcp.2008.11.014","article-title":"CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways","volume":"77","author":"Huang","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0270","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jcp.21783","article-title":"CCL5\/CCR5 axis promotes the motility of human oral cancer cells","volume":"220","author":"Chuang","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0275","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbagen.2009.07.015","article-title":"Syndecan-1 and syndecan-4 are involved in RANTES\/CCL5-induced migration and invasion of human hepatoma cells","volume":"1790","author":"Charni","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jprot.2013.09.013_bb0280","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pros.20306","article-title":"Expression of CCL5 (RANTES) and CCR5 in prostate cancer","volume":"66","author":"Vaday","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.jprot.2013.09.013_bb0285","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jprot.2013.09.013_bb0290","first-page":"103","article-title":"Maraviroc approved as a CCR5 co-receptor antagonist","volume":"22","author":"FDA notifications","year":"2007","journal-title":"AIDS Alert"},{"key":"10.1016\/j.jprot.2013.09.013_bb0295","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1158\/0008-5472.CAN-11-3917","article-title":"CCR5 antagonist blocks metastasis of basal breast cancer cells","volume":"72","author":"Velasco-Velazquez","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0300","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4049\/jimmunol.141.3.1018","article-title":"A human T cell-specific molecule is a member of a new gene family","volume":"141","author":"Schall","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0305","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","article-title":"The biology of chemokines and their receptors","volume":"18","author":"Rossi","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0315","first-page":"4681","article-title":"Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma","volume":"59","author":"Luboshits","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0320","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.onc.1210662","article-title":"Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5\/RANTES","volume":"27","author":"Borczuk","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jprot.2013.09.013_bb0325","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","article-title":"The inflammatory chemokines CCL2 and CCL5 in breast cancer","volume":"267","author":"Soria","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jprot.2013.09.013_bb0330","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.182.3.1746","article-title":"Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer","volume":"182","author":"Tan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0335","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/0008-5472.CAN-11-2493","article-title":"Tumor-derived chemokine CCL5 enhances TGF-beta-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells","volume":"72","author":"Chang","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0340","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.4049\/jimmunol.0990015","article-title":"The unexpected pleiotropic activities of RANTES","volume":"182","author":"Levy","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0345","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1021\/pr0500760","article-title":"The platelet microparticle proteome","volume":"4","author":"Garcia","year":"2005","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0350","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2007-09-112128","article-title":"Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes","volume":"111","author":"Ma","year":"2008","journal-title":"Blood"},{"issue":"M111","key":"10.1016\/j.jprot.2013.09.013_bb0355","first-page":"008599","article-title":"Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers","volume":"10","author":"Makawita","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2013.09.013_bb0360","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2006.01.029","article-title":"Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder","volume":"102","author":"Tsukishiro","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jprot.2013.09.013_bb0365","first-page":"285","article-title":"Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer","volume":"7","author":"Niwa","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jprot.2013.09.013_bb0370","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0959-8049(02)00596-8","article-title":"Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor","volume":"39","author":"Kim","year":"2003","journal-title":"Eur J Cancer"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187439191300479X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187439191300479X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T06:33:26Z","timestamp":1716014006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187439191300479X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":74,"alternative-id":["S187439191300479X"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2013.09.013","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-molecular-mass secretome profiling identifies C\u2013C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2013.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}